Form 4: Marcus Lemonis Granted 1.5M Restricted Stock Units
Insider Transaction Report
Marcus Lemonis, Executive Chairman & CEO of Bed Bath & Beyond, Inc., has been granted 1,500,000 restricted stock units following shareholder approval.
Summary
- Marcus Lemonis, Executive Chairman & CEO of Bed Bath & Beyond, Inc., received a grant of 1,500,000 restricted stock units (RSUs).
- The grant was made on March 11, 2026, and became effective on May 14, 2026, after receiving necessary shareholder approval.
- These RSUs represent a contingent right to receive one share of Bed Bath & Beyond common stock each.
- The RSUs will vest in four equal installments on January 1 of 2027, 2028, 2029, and 2030.
- Vested shares will be delivered to Mr. Lemonis promptly after vesting.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a moderately positive development, reflecting executive commitment and potential alignment with shareholder interests, though the lack of performance metrics for the RSUs limits a stronger positive assessment.
Positives
- Grant of a significant number of restricted stock units (1,500,000) to key executive, Marcus Lemonis, indicating potential alignment of executive interests with long-term shareholder value.
- Shareholder approval was obtained for the RSU grant, suggesting a level of confidence from the shareholder base in the executive compensation structure.
- The vesting schedule is spread over several years (2027-2030), which encourages long-term commitment and performance from the executive.
Negatives
- The filing does not provide details on the performance conditions or metrics tied to the vesting of these RSUs, making it difficult to assess if they are performance-based or solely time-based.
- The company's financial health and market performance are not detailed in this specific filing, which is a Form 4 reporting a stock grant.
Risks
- The value of the restricted stock units is directly tied to the future performance and stock price of Bed Bath & Beyond, Inc., which could be volatile.
- Failure to meet any unstated performance conditions could result in the forfeiture of these RSUs.
- The company's overall financial stability and competitive landscape present inherent risks to the value of any equity compensation.
Future Outlook
The vesting schedule for the 1,500,000 restricted stock units granted to Marcus Lemonis extends through January 1, 2030, with vested shares to be delivered promptly after vesting.
Industry Context
StockSavvy.ai notes that the granting of significant equity awards to top executives is a common practice across the retail sector to incentivize performance and retain talent, especially during periods of corporate transformation or restructuring.
Stakeholder Impact
- Shareholders: The grant of RSUs to a key executive may be viewed positively as it aligns executive interests with long-term company performance, provided the company performs well.
- Employees: May see this as a sign of executive commitment, but the direct impact on employees is not specified.
- Creditors: The grant of equity does not directly impact creditors, but the company's overall performance, which this grant aims to influence, is relevant.
Next Steps
- Vesting of restricted stock units on January 1 of 2027, 2028, 2029, and 2030.
- Delivery of vested shares to Marcus Lemonis promptly after each vesting date.
Key Dates
| Date | Description |
|---|---|
| 03/11/2026 | Date restricted stock units were granted. |
| 05/14/2026 | Date shareholder approval was received, making the grant effective. |
| 01/01/2027 | First installment of RSUs vests. |
| 01/01/2028 | Second installment of RSUs vests. |
| 01/01/2029 | Third installment of RSUs vests. |
| 01/01/2030 | Fourth and final installment of RSUs vests. |
| 05/18/2026 | Date the Form 4 was signed. |
Keywords
Marcus Lemonis, Bed Bath & Beyond, BBBY, Restricted Stock Units, RSU Grant, Executive Compensation, SEC Form 4, Insider Trading, Shareholder Approval, Vesting Schedule
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.